Archive | Melanoma In The News

Researchers find cellular sweet spot in skin-cancer battle

A team of researchers has pinpointed a sugar modification in cells that spurs the spread of skin cancer. Its findings, which appear in the latest issue of the journal Cancer Cell, spotlight a target in the battle against melanoma.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Melanoma-Specific Survival With Completion Dissection vs Observation for Sentinel Node Metastasis

The phase III MSLT-II trial showed that completion dissection was not associated with improved melanoma-specific overall survival vs observation in patients with sentinel node metastasis, although a benefit was observed in regional disease control.

Read the full story

Posted in Melanoma In The News, Clinical Trials

ANGPT2: Promising Biomarker for Checkpoint Response

Early results show that angiopoietin-2 (ANGPT2), a serum-based protein, may provide an easy way to identify which patients with metastatic melanoma will respond to immune checkpoint therapy, according to investigators at the Dana-Farber Cancer Institute, in Boston.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Glembatumumab Vedotin Shows Promising Overall Response in Advanced Melanoma

Patients with refractory advanced melanoma who had received prior treatment with a checkpoint inhibitor demonstrated promising overall response rate (ORR) and duration of response (DOR) in a phase II study involving the antibody-drug conjugate (ADC) glembatumumab vedotin (GV).

Read the full story

Posted in Melanoma In The News, Clinical Trials

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories